X4 Pharmaceuticals to Report Second-Quarter 2023 Financial Results and Host a Conference Call and Webcast on August 10, 2023
BOSTON, Aug. 02, 2023 (GLOBE NEWSWIRE) — X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the…
BOSTON, Aug. 02, 2023 (GLOBE NEWSWIRE) — X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the…
BOSTON, Aug. 02, 2023 (GLOBE NEWSWIRE) — X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the…
NEEDHAM, Mass., Aug. 02, 2023 (GLOBE NEWSWIRE) — Candel Therapeutics, Inc. (Candel or the Company)…
NEEDHAM, Mass., Aug. 02, 2023 (GLOBE NEWSWIRE) — Candel Therapeutics, Inc. (Candel or the Company)…
LEOPARD trial initiation follows recent positive data from OCS-01 eye drops from the Stage 1…
LEOPARD trial initiation follows recent positive data from OCS-01 eye drops from the Stage 1…
PRINCETON, N.J., Aug. 02, 2023 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage…
PRINCETON, N.J., Aug. 02, 2023 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage…
Three New IVL-Specific Diagnostic Related Groups (DRGs) with Increased Payments Go Into Effect October 1,…
Three New IVL-Specific Diagnostic Related Groups (DRGs) with Increased Payments Go Into Effect October 1,…
WARREN, N.J., Aug. 02, 2023 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST) (the “Company”…
WARREN, N.J., Aug. 02, 2023 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST) (the “Company”…
DUBLIN, Ireland, Aug. 02, 2023 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical…
DUBLIN, Ireland, Aug. 02, 2023 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical…
Management to present on Thursday, August 10 at 12:30-12:55 PM Eastern Time at the InterContinental…
Management to present on Thursday, August 10 at 12:30-12:55 PM Eastern Time at the InterContinental…
Data published in Frontiers in Immunology show a robust safety profile and rapid resolution from…
Data published in Frontiers in Immunology show a robust safety profile and rapid resolution from…
SAN DIEGO, Aug. 02, 2023 (GLOBE NEWSWIRE) — Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech…
SAN DIEGO, Aug. 02, 2023 (GLOBE NEWSWIRE) — Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech…